A citation-based method for searching scientific literature

Logan C Walker, Margaret McDonald, J Elisabeth Wells, Gavin C Harris, Bridget A Robinson, Christine M Morris. PLoS One 2013
Times Cited: 8







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, Suet-Feung Chin, Gulisa Turashvili, Oscar M Rueda, Mark J Dunning, Doug Speed, Andy G Lynch, Shamith Samarajiwa, Yinyin Yuan,[...]. Nature 2012
25

Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer.
Sehwan Han, Kyeongmee Park, Eunah Shin, Hyun-Jung Kim, Jung Yeon Kim, Ji Young Kim, Geumhee Gwak. Oncol Rep 2010
14
25

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
Alexander T El Gammal, Michael Brüchmann, Jozef Zustin, Hendrik Isbarn, Olaf J C Hellwinkel, Jens Köllermann, Guido Sauter, Ronald Simon, Waldemar Wilczak, Jörg Schwarz,[...]. Clin Cancer Res 2010
93
25

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
25

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
25

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Ka Lung Wu, Berna Beverloo, Henk M Lokhorst, Christine M Segeren, Bronno van der Holt, Monique M Steijaert, Petra H Westveer, Pino J Poddighe, Gregor E Verhoef, Pieter Sonneveld. Br J Haematol 2007
38
12

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
John D Shaughnessy, Fenghuang Zhan, Bart E Burington, Yongsheng Huang, Simona Colla, Ichiro Hanamura, James P Stewart, Bob Kordsmeier, Christopher Randolph, David R Williams,[...]. Blood 2007
627
12


TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.
Outi R Saramäki, Anna E Harjula, Paula M Martikainen, Robert L Vessella, Teuvo L J Tammela, Tapio Visakorpi. Clin Cancer Res 2008
190
12

Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma.
Norma C Gutiérrez, Juan L García, Jesús M Hernández, Eva Lumbreras, Mariana Castellanos, Ana Rasillo, Gema Mateo, José M Hernández, Sonia Pérez, Alberto Orfao,[...]. Blood 2004
73
12


Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.
B C Bastian, P E LeBoit, H Hamm, E B Bröcker, D Pinkel. Cancer Res 1998
385
12

Hypodiploidy is a major prognostic factor in multiple myeloma.
N V Smadja, C Bastard, C Brigaudeau, D Leroux, C Fruchart. Blood 2001
266
12

Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses.
Aliaksei Chyhrai, Jimsgene Sanjmyatav, Mieczyslaw Gajda, Olaf Reichelt, Heiko Wunderlich, Thomas Steiner, Enis Tanović, Kerstin Junker. World J Urol 2010
22
12

ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC.
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli. Target Oncol 2013
58
12

Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.
Nikesh Kawankar, Farah Jijina, Kanjaksha Ghosh, Babu Rao Vundinti. Cancer Epidemiol 2011
4
25


Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
M Hallek, K Fischer, G Fingerle-Rowson, A M Fink, R Busch, J Mayer, M Hensel, G Hopfinger, G Hess, U von Grünhagen,[...]. Lancet 2010
12

Automated evaluation of Her-2/neu status in breast tissue from fluorescent in situ hybridization images.
Francesco Raimondo, Marios A Gavrielides, Georgia Karayannopoulou, Kleoniki Lyroudia, Ioannis Pitas, Ioannis Kostopoulos. IEEE Trans Image Process 2005
32
12

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
12

New therapeutical strategies in the treatment of metastatic disease.
Fanny Julia, Luc Thomas, Stéphane Dalle. Dermatol Ther 2012
12
12

Chromosomal aberrations by 4-color fluorescence in situ hybridization not detected in Spitz nevi of older individuals.
Basil A Horst, Yuqiang Fang, David N Silvers, Klaus J Busam. Arch Dermatol 2012
7
14

Equivocal cytology in lung cancer diagnosis: improvement of diagnostic accuracy using adjuvant multicolor FISH, DNA-image cytometry, and quantitative promoter hypermethylation analysis.
Martin Schramm, Christian Wrobel, Ingmar Born, Marietta Kazimirek, Natalia Pomjanski, Marina William, Rainer Kappes, Claus Dieter Gerharz, Stefan Biesterfeld, Alfred Böcking. Cancer Cytopathol 2011
25
12

Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
Roman Rouzier, Charles M Perou, W Fraser Symmans, Nuhad Ibrahim, Massimo Cristofanilli, Keith Anderson, Kenneth R Hess, James Stec, Mark Ayers, Peter Wagner,[...]. Clin Cancer Res 2005
12

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
R Itzykson, O Kosmider, T Cluzeau, V Mansat-De Mas, F Dreyfus, O Beyne-Rauzy, B Quesnel, N Vey, V Gelsi-Boyer, S Raynaud,[...]. Leukemia 2011
359
12

MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.
Guohong Hu, Robert A Chong, Qifeng Yang, Yong Wei, Mario A Blanco, Feng Li, Michael Reiss, Jessie L-S Au, Bruce G Haffty, Yibin Kang. Cancer Cell 2009
321
12

Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.
Muzaffar H Qazilbash, Rima M Saliba, Bilal Ahmed, Gaurav Parikh, Floralyn Mendoza, Noman Ashraf, Chitra Hosing, Thuy Flosser, Donna M Weber, Michael Wang,[...]. Biol Blood Marrow Transplant 2007
27
12

Molecular profiles of progesterone receptor loss in human breast tumors.
Chad J Creighton, C Kent Osborne, Marc J van de Vijver, John A Foekens, Jan G Klijn, Hugo M Horlings, Dimitry Nuyten, Yixin Wang, Yi Zhang, Gary C Chamness,[...]. Breast Cancer Res Treat 2009
75
12

Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array study.
Alma Carracedo, Marta Salido, Josep M Corominas, Federico Rojo, Bibiana I Ferreira, Javier Suela, Ignasi Tusquets, Cristina Corzo, Marcel Segura, Blanca Espinet,[...]. Cancer Genet 2012
9
12



What's new in prognostication of melanoma in the dermatopathology laboratory?
Haider K Bangash, Alison Romegialli, Soheil S Dadras. Clin Dermatol 2013
3
33

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.
R Fonseca, M M Oken, D Harrington, R J Bailey, S A Van Wier, K J Henderson, N E Kay, B Van Ness, P R Greipp, G W Dewald. Leukemia 2001
96
12

Breast tumor copy number aberration phenotypes and genomic instability.
Jane Fridlyand, Antoine M Snijders, Bauke Ylstra, Hua Li, Adam Olshen, Richard Segraves, Shanaz Dairkee, Taku Tokuyasu, Britt Marie Ljung, Ajay N Jain,[...]. BMC Cancer 2006
212
12

Multiple myeloma: evolving genetic events and host interactions.
W Michael Kuehl, P Leif Bergsagel. Nat Rev Cancer 2002
598
12

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
Juan-Miguel Mosquera, Rohit Mehra, Meredith M Regan, Sven Perner, Elizabeth M Genega, Gerri Bueti, Rajal B Shah, Sandra Gaston, Scott A Tomlins, John T Wei,[...]. Clin Cancer Res 2009
169
12

Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases.
Zenonas Theodosiou, Ioannis N Kasampalidis, Georgia Karayannopoulou, Ioannis Kostopoulos, Mattheos Bobos, Generoso Bevilacqua, Paolo Aretini, Antonina Starita, Kleoniki Lyroudia, Ioannis Pitas. Breast 2008
15
12

Novel patterns of genome rearrangement and their association with survival in breast cancer.
James Hicks, Alexander Krasnitz, B Lakshmi, Nicholas E Navin, Michael Riggs, Evan Leibu, Diane Esposito, Joan Alexander, Jen Troge, Vladimir Grubor,[...]. Genome Res 2006
244
12

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.
G Attard, J Clark, L Ambroisine, G Fisher, G Kovacs, P Flohr, D Berney, C S Foster, A Fletcher, W L Gerald,[...]. Oncogene 2008
349
12

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
F Demichelis, K Fall, S Perner, O Andrén, F Schmidt, S R Setlur, Y Hoshida, J-M Mosquera, Y Pawitan, C Lee,[...]. Oncogene 2007
475
12

HER2 as a prognostic factor in breast cancer.
S Ménard, S Fortis, F Castiglioni, R Agresti, A Balsari. Oncology 2001
167
12


[Detection of heterogeneity and evolution of subclones in t(8;21) AML by QM-FISH].
Ying-chan Wang, Lin-ping Hu, Dong Lin, Cheng-wen Li, Tian Yuan, Yu-jiao Jia, Zheng Tian, Ke-jing Tang, Min Wang, Jian-xiang Wang. Zhonghua Xue Ye Xue Za Zhi 2013
3
33

Crizotinib in the treatment of non--small-cell lung cancer.
Sacha I Rothschild, Oliver Gautschi. Clin Lung Cancer 2013
28
12

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
Koei Chin, Sandy DeVries, Jane Fridlyand, Paul T Spellman, Ritu Roydasgupta, Wen-Lin Kuo, Anna Lapuk, Richard M Neve, Zuwei Qian, Tom Ryder,[...]. Cancer Cell 2006
914
12

Refining the diagnosis and prognostic categorization of acute myeloid leukemia patients with an integrated use of cytogenetic and molecular studies.
Dolors Costa, Anna Vidal, Ana Carrió, Concha Muñoz, Amparo Arias, Cándida Gómez, Daniela Berneaga, Dolors Colomer, Maria Rozman, Marta Pratcorona,[...]. Acta Haematol 2013
1
100

Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.
Andrew J Weickhardt, Dara L Aisner, Wilbur A Franklin, Marileila Varella-Garcia, Robert C Doebele, D Ross Camidge. Cancer 2013
55
12


Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?
Vera Ademà, Jesús María Hernández, María Abáigar, Eva Lumbreras, Esperanza Such, Anna Calull, Esther Dominguez, Leonor Arenillas, Mar Mallo, José Cervera,[...]. Leuk Res 2013
12
12

Intratumoral patterns of clonal evolution in gliomas.
Ana Luísa Vital, Maria Dolores Tabernero, Inês Crespo, Olinda Rebelo, Hermínio Tão, Fernando Gomes, Maria Celeste Lopes, Alberto Orfao. Neurogenetics 2010
17
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.